Vical Provides Company Update at BIO CEO and Investor Conference
February 07 2017 - 6:30AM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will provide an overview of its technologies, development programs,
and outlook at 1:00 p.m. EST on Tuesday, February 14, at the
Biotechnology Innovation Organization (BIO) CEO and Investor
Conference (New York – February 13-14). A webcast of the company’s
presentation will be available live and archived through the Events
& Presentations page in the Investors section of the Vical
website at www.vical.com.
About VicalVical develops
biopharmaceutical products for the prevention and treatment of
chronic or life-threatening infectious diseases, based on its
patented DNA delivery technologies and other therapeutic
approaches. Additional information on Vical is available at
www.vical.com.
Contact:
Tony Ramos
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From Apr 2023 to Apr 2024